{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:24:59Z","timestamp":1789691099637,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.urolonc.2005.05.028","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T07:31:26Z","timestamp":1132644686000},"page":"386-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Gu\u00e9rin for carcinoma in situ of the bladder: A Southwest Oncology Group Study"],"prefix":"10.1016","volume":"23","author":[{"given":"Michael F.","family":"Sarosdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Tangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey R.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake R.","family":"Nestok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell C.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Schellhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur I.","family":"Sagalowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"David P.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. David","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2005.05.028_bib1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacillus Calmette-Guerin for transitional cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2005.05.028_bib2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0022-5347(17)37532-8","article-title":"Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer","volume":"147","author":"Morales","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.05.028_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-5347(17)32741-6","article-title":"Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy","volume":"152","author":"Nadler","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.05.028_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0163-7258(85)90048-8","article-title":"Antiviral and other bioactivities of pyrimidinones","volume":"30","author":"Wierenga","year":"1985","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.urolonc.2005.05.028_bib5","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4049\/jimmunol.132.5.2566","article-title":"Stimulation of natural killer cells in two random-bred strains of athymic mice by interferon-inducing pyrimidinones","volume":"132","author":"Lotzova","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2005.05.028_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-5347(17)37126-4","article-title":"Phase I trial of oral bropirimine in superficial bladder cancer","volume":"147","author":"Sarosdy","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.05.028_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0090-4295(96)90059-X","article-title":"Oral bropirimine immunotherapy of carcinoma in situ of the bladder","volume":"48","author":"Sarosdy","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2005.05.028_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0090-4295(96)00080-5","article-title":"Bropirimine immunotherapy of upper urinary tract carcinoma in situ","volume":"48","author":"Sarosdy","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2005.05.028_bib9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39103-6","article-title":"Combination immunotherapy of murine transitional cell carcinoma using BCG and an interferon-inducing pyrimidinone","volume":"142","author":"Sarosdy","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.05.028_bib10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance BCG immunotherapy in recurrent TA, T1 and carcinoma in situ transitional cell carcinoma","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.05.028_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-5347(17)39547-2","article-title":"A randomized controlled study of intravesical alpha-2b-interferon in carcinoma in situ of the bladder","volume":"144","author":"Glashan","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.05.028_bib12","first-page":"494A","article-title":"Pilot study of intravesical alfa-2b interferon for treatment of bladder carcinoma in situ following BCG failure","volume":"155","author":"Williams","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.05.028_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0090-4295(97)00067-8","article-title":"Additional bacillus Calmette-Guerin therapy for recurrent transitional cell carcinoma after an initial complete response","volume":"49","author":"Bui","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2005.05.028_bib14","first-page":"581","article-title":"Photodynamic therapy for urologic malignancies","volume":"19","author":"Manayak","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2005.05.028_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0090-4295(00)00654-3","article-title":"Pilot study of the tolerability and toxicity of intravesical valrubicin immediately after transurethral resection of superficial bladder cancer","volume":"56","author":"Patterson","year":"2000","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143905001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143905001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:51:03Z","timestamp":1761040263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143905001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1078143905001213"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2005.05.028","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Gu\u00e9rin for carcinoma in situ of the bladder: A Southwest Oncology Group Study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2005.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}